These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3545719)

  • 1. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo.
    Greenbaum DS; Mayle JE; Vanegeren LE; Jerome JA; Mayor JW; Greenbaum RB; Matson RW; Stein GE; Dean HA; Halvorsen NA
    Dig Dis Sci; 1987 Mar; 32(3):257-66. PubMed ID: 3545719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy.
    Greenbaum DS
    Psychopharmacol Bull; 1984; 20(4):622-8. PubMed ID: 6149598
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.
    Drossman DA; Toner BB; Whitehead WE; Diamant NE; Dalton CB; Duncan S; Emmott S; Proffitt V; Akman D; Frusciante K; Le T; Meyer K; Bradshaw B; Mikula K; Morris CB; Blackman CJ; Hu Y; Jia H; Li JZ; Koch GG; Bangdiwala SI
    Gastroenterology; 2003 Jul; 125(1):19-31. PubMed ID: 12851867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome].
    Cargill G; Salin B; Lubin S; Kohler F; Coste T; Rautureau J
    Presse Med; 1992 Jan 4-11; 21(1):19-23. PubMed ID: 1531259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
    Camilleri M; Chey WY; Mayer EA; Northcutt AR; Heath A; Dukes GE; McSorley D; Mangel AM
    Arch Intern Med; 2001 Jul; 161(14):1733-40. PubMed ID: 11485506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients.
    Whitehead WE; Engel BT; Schuster MM
    Dig Dis Sci; 1980 Jun; 25(6):404-13. PubMed ID: 7379673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome.
    Noor N; Small PK; Loudon MA; Hau C; Campbell FC
    Scand J Gastroenterol; 1998 Jun; 33(6):605-11. PubMed ID: 9669632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.
    Cook IJ; Irvine EJ; Campbell D; Shannon S; Reddy SN; Collins SM
    Gastroenterology; 1990 Jan; 98(1):66-72. PubMed ID: 2152777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride).
    Page JG; Dirnberger GM
    J Clin Gastroenterol; 1981 Jun; 3(2):153-6. PubMed ID: 7016973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance for rectosigmoid distention in irritable bowel syndrome.
    Whitehead WE; Holtkotter B; Enck P; Hoelzl R; Holmes KD; Anthony J; Shabsin HS; Schuster MM
    Gastroenterology; 1990 May; 98(5 Pt 1):1187-92. PubMed ID: 2323511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic sensitive-motor alterations in the irritable bowel syndrome.
    Tomas-Ridocci M; Moreno-Osset E; Minguez M; Ballester J; Mora F; Benages A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):48-52. PubMed ID: 1756283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1206-11. PubMed ID: 8138933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral cisapride on small bowel motility in irritable bowel syndrome.
    Evans PR; Bak YT; Kellow JE
    Aliment Pharmacol Ther; 1997 Oct; 11(5):837-44. PubMed ID: 9354190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of loperamide and placebo in management of irritable bowel syndrome (IBS).
    Cann PA; Read NW; Holdsworth CD; Barends D
    Dig Dis Sci; 1984 Mar; 29(3):239-47. PubMed ID: 6365490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.